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Serotonin systemsNerve gas organophosphates like sarin are likely to be used in urban terrorism, leading to widespread
exposures of pregnant women and young children. Here, we established a model for sarin neurobehavioral
teratogenicity in the developing chick so as to explore the consequences of apparently subtoxic sarin
exposure and the mechanisms underlying synaptic and behavioral deﬁcits. Chicken eggs were injected with
sarin (2, 6 and 12 μg/kg) on incubation days 2 and 6, treatments that did not decrease hatching and did not
evoke dysmorphology. After hatching the chicks were tested for ﬁlial imprinting and neurochemical markers
known to be critical for imprinting. Imprinting was reduced at 2 and 6 μg/kg but not at the highest dose.
Acetylcholinesterase and choline acetyltransferase were unaffected but sarin reduced the concentration of
the high-afﬁnity choline transporter, the rate-limiting factor in acetylcholine utilization. The concentration of
PKC isoforms was assessed in the imprinting-related intermediate part of the medial hyperstriatum ventrale,
the region most closely associated with cholinergic function in imprinting behavior. Sarin reduced the
concentration of all isoforms (α, β, γ) with a similar, biphasic dose–response curve to that seen for
behavioral performance, a relationship noted in previous work with organophosphate pesticides. Our results
indicate that otherwise subtoxic exposures to sarin produce neurodevelopmental deﬁcits; since we utilized a
chick model, which is devoid of maternal confounds that are present in mammalian development, the
adverse effects of sarin are mediated directly in the developing organism.
© 2009 Elsevier Inc. All rights reserved.1. Introduction
Sarin, a potent organophosphate and acetylcholinesterase inhib-
itor [12], is among the nerve agents most likely to be used on the
battle ﬁeld or in a terrorist attack, such as that experienced in the
Tokyo subway [20]. Adult human and animal studies have demon-
strated long lasting neurological abnormalities among survivors of
sarin exposure who showed initial, acute signs of toxicity [20,39].
However, there is obviously a much wider circle of individuals who
are exposed at lower, nonsymptomatic levels, about which much less
is known. In particular, an urban terrorist incident will almost
assuredly involve numerous pregnant women and young children
who may not display acute toxicity; nevertheless, because of the
higher vulnerability of the developing brain to neurotoxic insult, theseholine acetyltransferase; HC3,
l hyperstriatum ventrale; PKC,
udies in Neural Birth Defects,
University–Hadassah Medical
l rights reserved.children may nevertheless manifest long-term deﬁcits in brain
development and function. It is therefore critical to establish an
animal model for nerve agent neurobehavioral teratogenicity,
including elucidation of the synaptic mechanisms by which the
nerve gas agents might produce behavioral deﬁcits after develop-
mental exposure.
Although organophosphates as a chemical class, share the ability
to inhibit cholinesterase [19], their adverse effects on brain develop-
ment reﬂect families of mechanisms that operate below the threshold
for cholinesterase inhibition and therefore are not shared equally.
These diverse outcomes are especially apparent at low levels of
exposure that elicit no initial signs of toxicity (review, [29]).
Accordingly, whereas a large body of literature has examined the
mechanisms and consequences of neurobehavioral teratogenicity of
organophosphate pesticides, this information may not necessarily
apply to a shorter-acting but more potent nerve agent like sarin. It is
therefore important to note that, to date, there is apparently no
published literature on the neurodevelopmental effects of sarin or
related nerve gas organophosphates. Here, we present a chick model
of sarin neurobehavioral teratogenicity that parallels our previous
work with the organophosphate pesticide, chlorpyrifos. Chlorpyrifos
evokes widespread disruption of neuronal cell replication and
differentiation, culminating in abnormalities of synaptic function
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especially those involving acetylcholine and serotonin [29]. Thus, in
mammalian models, fetal or neonatal chlorpyrifos exposure leads to
cognitive deﬁcits involving impaired presynaptic cholinergic function
in critical regions such as the hippocampus, striatum and cerebral
cortex [29]. Postsynaptically, the behavioral impairment was closely
associated with deﬁcits in receptor-mediated cell signaling cascades,
involving both cyclic AMP-dependent pathways and those governed
by protein kinase C (PKC).
Notwithstanding these results, mammalian models are always
subject to confounds that result from toxicant effects in the mother,
the maternal–fetal unit, or maternal–neonatal interactions. These
include potential effects of the agent on maternal body temperature
or oxygenation [24], maternal stress [38], or the “litter” effect [33],
which involves nest-making, pup retrieval littermate competition for
teats, and pup vocalizations that trigger suckling and maternal care
[2,8,23] none of which are directly operational in humans. Recently,
we developed an avian model for studies of developmental neuro-
toxicity to obviate these confounds [10]. With chicks, we can
administer agents directly to the medium surrounding the embryo,
eliminating the variables related to maternal physiology in mamma-
lian models. During the early incubation period, the ﬂuid volume of
the chick egg is large compared to the embryo, so that the exposure is
uniform. Cognitive performance and its neurochemical underpinnings
can be tested right after hatching, before the chicks consume food or
water, and are thus independent of any potential changes in self-
sufﬁciency. On the other hand, the chick model is limited in that it
cannot recapitulate the pharmacokinetics of the maternal–fetal unit,
or other aspects of development that are speciﬁcally mammalian.
We used the chick model to evaluate the effects of prehatch
exposure to chlorpyrifos, which elicited severe deﬁcits in imprinting
behavior, a direct parallel to cognitive tests in mammals, involving
cholinergic function in a speciﬁc region, the left side of the intermedial
part of the hyperstriatum ventrale (IMHV), which parallels the
function of the mammalian hippocampus [10,32]. Our ﬁndings
recapitulated our earlier work in the rodent model, demonstrating
cognitive impairment, reductions in the presynaptic high-afﬁnity
choline transporter and abolition of cholinergic-induced PKCγ
translocation/activation, all of which were present with otherwise
subtoxic exposures. In the current study, we performed correspond-
ing work using sarin. As in our study with chlorpyrifos, we adminis-
tered sarin beginning early in development, paralleling rodent
models with treatment in early gestation, which are known to pro-
duce deﬁcits in both the cholinergic synaptic function and related
behaviors [29].
We evaluated cholinesterase activity to conﬁrm that the doses of
sarin did not lead to persistent cholinesterase inhibition. We used
imprinting to evaluate impaired behavioral performance and then
evaluated potential, mechanistically-related aspects of cholinergic
synaptic function known to be targets for organophosphate-induced
developmental neurotoxicity. For presynaptic function, we assayed
choline acetyltransferase (ChAT) activity, and binding of hemicholi-
nium-3 (HC3) to the presynaptic high-afﬁnity choline transporter.
ChAT, the enzyme that synthesizes acetylcholine, is a constitutive
component of cholinergic nerve terminals and thus provides a
measure of the development of cholinergic projections [9,22,30]. In
contrast, HC3 binding to the choline transporter is responsive to
neuronal activity [13,27], so that measurement of both parameters
enables the distinction between effects on the development of
innervation from those on synaptic activity. These markers have
been used previously to characterize effects of chlorpyrifos on
cholinergic systems in adult rats [18,17] and to evaluate the
immediate and delayed effects of developmental chlorpyrifos expo-
sure in rodents, PC12 [21,30,31] and chicks [32]. Finally, we evaluated
the concentration of PKC isoforms related to cholinergic behavioral
function in the IMHV [1,10,26].2. Methods
2.1. Treatments
All animal studies were reviewed and approved by the Duke
University Institutional Animal Care and Use Committee, in accordance
with all federal, state and local regulations. Fertile Leghorn-line chicken
eggs (Gallus gallus domesticus) were purchased from the Department of
Animal and Food Science, University of Delaware (Newark, DE), and an
injectionwindowwas preparedby drilling a hole in the pointed end and
sealing it with medical silicon (Dow Corning Type A). Eggs were
weighed and, after correcting for shell weight (11%), the concentration
of sarin was adjusted to deliver 2, 6 or 12 μg/kg in a volume of 3 μl on
incubationdays 2 and6. Sarinwasdissolved in salinevehicle andcontrol
eggs received an equivalent volume of vehicle. Sarin treatment was
carried out under a subcontract to the United States Army Medical
Research Institute of Chemical Defense (Aberdeen Proving Ground,
MD). The eggs were placed in a commercial incubator and a week after
the second injection, were transported via ground vehicle to Duke
University Medical Center in an incubator. Embryonic survival was
monitored via candling and at the end of the incubation period, the
hatch rate and physical attributes were noted.
2.2. Imprinting
The apparatus has been described in detail earlier [10]. Brieﬂy, we
used a box containing three 20 cm diameter running wheels with the
sides covered in blackmetal, permitting the chicks to see only forward
or backward. The imprinting objects were an illuminated red box
(15×10×18 cm high) or a blue cylinder with black stripes (13.5 cm
diameter×15.5 cm high), located 50 cm from the front, open side of
the running wheel, lit from within by a 40 W bulb with holes covered
with red or blue ﬁlters, and rotated at 30 rpm.
The chicks were hatched in total darkness and handling was done
in the dark, aided by a dim green light, which has a minimal effect on
imprinting. Each chick was transferred to an individual dark, enclosed
wooden chamber warmed to 30 °C, where they were physically and
visually isolated from each other. Twenty to 26 h posthatch, the chicks
underwent 45 min of “priming,” a 30 min exposure to a light (60 W
bulb) followed by 15 min of darkness. Immediately after, they were
placed individually on the runningwheel for training. The chicks were
divided into groups trained for 60 min with either blue or red
imprinting objects. The numbers of wheel rotations made by the chick
towards the imprinting object were recorded by videotaping and
scored by a blinded observer. After training, the chicks were returned
to the enclosed chambers for 60 min, after which testing took place.
Recorded maternal calls were played continually throughout training
but not during testing.
There were four testing sessions in counterbalanced randomized
order, each lasting 5 min; in two of the tests, the chick was allowed to
run toward the imprinting rotating object and in the other two,
toward the control object. The red-light box was used as the
imprinting object and the blue-light box served as the control object
for chicks trained to follow a red object and vice versa for the chicks
trained to follow the blue-light box. The number of wheel rotations
completed by the chick toward the imprinting or the novel (control)
object was recorded. The imprinting is expressed as a preference score
calculated as the number of rotations toward the imprinted light
divided by the total number of rotations combined from the test with
the imprinted light and the control light. Thus, a perfect score would
be 1.0 whereas no imprinting would result in a score of 0.5.
2.3. Neurochemistry
Chicks were decapitated immediately after behavioral testing and
the brain was dissected into the cerebral cortex, striatum, cerebellum,
Fig. 1. Imprinting performance in control chicks and chicks with prehatch exposure to
sarin, calculated as the preference ratio. Data represent mean±SEM. ANOVA and the
number of determinations in each group appear at the top of the panel and asterisks
denote signiﬁcant differences from the control values.
Fig. 2. Effects of prehatch sarin exposure on cholinesterase activity (A) and ChAT
activity (B). Data represent mean±SEM, presented as the percent change from control
values, which were: cholinesterase, 290±11 nmol/min per mg protein for rest of brain,
214±12 for cerebellum; choline acetyltransferase, 1736±38 pmol/min per mg protein
for brainstem, 922±31 for striatum, and 376±9 for cerebral cortex. ANOVA and the
number of determinations in each group appear at the top of the panel. NS, not
signiﬁcant.
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and stored at −45 °C until assayed. Cholinesterase measurements
were made on the cerebellum and the rest of the brain after removal
of the IMHV, which represents a minuscule proportion of the total
tissue weight (3 mg out of 630 mg). Tissues were thawed and
homogenized (Polytron, Brinkmann Instruments, Westbury, NY) in
ice-cold 50 mM Tris (pH 7.4), and aliquots of the homogenate were
withdrawn for measurement of total protein and cholinesterase
activity. The homogenate was diluted in 0.5% Triton X100, 0.1 M
Na2HPO4/KH2PO4 (pH 8) and left on ice for 15 min to allow the Triton
X100 to solubilize membrane-associated cholinesterase. Homoge-
nates were sedimented at 40,000× g for 15 min and aliquots of the
supernatant solution were added to ﬁnal concentrations of 0.5 mM
acetylthiocholine iodide and 0.33 mM 5,5′-dithiobis(2-nitrobenzoic
acid) in the same buffer without Triton (all reagents from Sigma
Chemical Co., St. Louis, MO). Assays were incubated at room
temperature for 4, 8, 12, 16 and 20 min, and the enzyme activity
was assessed from the linear portion of the time course, reading the
absorbance at 415 nm. The assay was standardized using mercap-
toethanol as a substrate and calculated relative to total protein.
For ChAT determinations, tissues were thawed in 79 volumes of
ice-cold 10 mM sodium–potassium phosphate buffer (pH 7.4) and
homogenized (Polytron). Assays contained 60 mM sodium phosphate
(pH 7.9), 200 mM NaCl, 20 mM choline chloride, 17 mMMgCl2, 1 mM
EDTA, 0.2% Triton X-100, 0.12 mM physostigmine, 0.6 mg/ml bovine
serum albumin and 50 μM [14C]acetyl-coenzyme A (PerkinElmer Life
Sciences, Boston, MA; speciﬁc activity 60 mCi/mmol, diluted with
unlabeled compound to 6.7 mCi/mmol). Samples were preincubated
for 15 min on ice, transferred to a 37 °C water bath for 30 min, and the
reaction terminated by placing the samples on ice. Labeled acetyl-
choline was then extracted, counted and the activity determined
relative to total protein.
For measurements of [3H]HC3 binding, the cell membrane fraction
was prepared by sedimenting an aliquot of the same tissue
homogenate at 40,000× g for 15 min. The membrane pellet was
resuspended (Polytron) in the original volume of sodium–potassium
phosphate buffer, resedimented, and the resultant pellet was
resuspended using a smooth glass homogenizer ﬁtted with a Teﬂon
pestle, in 10 mM sodium–potassium phosphate buffer (pH 7.4) and
150 mM NaCl. Radioligand binding was evaluated with 2 nM [3H]HC3
(PerkinElmer; speciﬁc activity 125 Ci/mmol), with incubation for
20min at room temperature, followed by rapid vacuum ﬁltration onto
glass ﬁber ﬁlters (presoaked for 30 min with 0.1% polyethyleneimine
in buffer). The nonspeciﬁc component was deﬁned as radioligand
binding in the presence of an excess concentration (10 μM) of
unlabeled HC3 (Sigma). Binding values were expressed relative to
membrane protein.
For PKC determinations, the left IMHV (~3.0 mg) was quickly
dissected [10], and frozen in liquid nitrogen. Basal levels of the PKC
isoforms γ, βII and α in the cytosolic and membrane fractions of the
IMHV were assayed using published protocols modiﬁed [10,25,34,40]
from earlier techniques [36]. The tissues were homogenized in buffer
and then sedimented at 100,000 ×g for 1 h at 4 °C, after which the
supernatant solution containing the cytosolic fraction was frozen. The
membrane pellet was resuspended and solubilized with 0.5% Triton
X-100, then sedimented as already described, and the supernatant
solution was frozen.
Western blot analysis was carried out by gel electrophoresis
(Invitrogen EP048-08, Carlsbad, CA) of 10–15 μg aliquots of cytosolic
and membrane protein using speciﬁc primary antibodies for each PKC
subtype. The PKCγ antibody 36G9 recognizes chick PKCγ [37] and was
produced especially for this study (E.A. Van der Zee), whereas cPKCβII
and pPKCα were purchased from Santa Cruz Biochemicals (Santa
Cruz, CA); IgG HRP conjugated (Bio-Rad) secondary antibody, was
then applied exactly as described earlier [25,40]. We did not assess
internal standards of structural “housekeeping” proteins (α-tubulinor β-actin) because many neuroteratogens, including the organopho-
sphates, inﬂuence neuromorphological development [6] and conse-
quently cause alterations in the expression of these cytoskeleton
proteins, unrelated to the neurobehavioral effects linked to speciﬁc
cell signaling pathways. Instead, to ensure standardization, triplicate
samples from all groups were run in proximity to each other on the
Fig. 3. Effects of prehatch sarin exposure on HC3 binding (A) and the ratio of HC3
binding to ChAT activity (B). Data represent mean±SEM, presented as the percent
change from control values, which were: HC3 binding, 18.7±0.5 fmol/mg protein for
brainstem, 23.8±1.0 for striatum, 12.9±0.5 for cerebral cortex; HC3/ChAT ratio, 11.0±
0.4 for brainstem, 26.0±1.0 for striatum, 34.0±1.5 for cerebral cortex. ANOVA and the
number of determinations in each group appear at the top of each panel. Asterisks
denote signiﬁcant differences for each treatment group from the corresponding control
values. Because of the absence of treatment (region interactions in (A), statistical
comparisons for each regionwere not carried out. For (B), themain effect of treatment in
each region is shown within the legend box and daggers indicate individual regional
values for each treatment group that were signiﬁcantly different from the control. NS,
not signiﬁcant.
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has precisely the same protein load. Since the levels are assessed as
changes from the matched control on the same gel, any inherent gel-
to-gel differences in hybridization or factors other than the speciﬁc
concentration of PKCγ and PKCβII are equally represented in both the
numerator and denominator and do not contribute to the measured
outcome.
2.4. Data analysis
All data are presented as means and standard errors. Treatment
effects on neurochemical and behavioral variables were examined by
multivariate nested ANOVAs, incorporating factors of treatment and,
for neurochemistry, the brain region (a repeated measure, since each
animal contributed multiple brain regions), followed, where permit-
ted by appropriate interaction terms, by lower-order ANOVAs and
Fisher's Protected Least Signiﬁcant Difference Test to evaluate speciﬁc
treatment groups that differed signiﬁcantly from the corresponding
control values. To enable convenient comparison of treatment effects
across different regions and measures, some data are presented as the
percent change from control, with the corresponding control valuespresented in the ﬁgure legends; however, statistical analyses were
always conducted on the original data.
For the PKC studies, each gel contained a sample representing one
individual from each treatment group; since the samples thus
involved multiple gels, the results were evaluated nonparametrically
as either an increase or a decrease relative to the paired control
sample. We then used χ2 analysis to determine if the treatments
altered the incidence of increases or decreases from the random value
of 50%. Where there was a signiﬁcant effect on the distribution of PKC
values, we then compiled the median increase or decrease as an index
of the magnitude of change. Signiﬁcance for all tests was assumed at
pb0.05.
3. Results
Sarin exposure did not decrease the hatch rate nor did it increase
the incidence of malformations (data not shown). Despite the absence
of overt teratogenesis or impaired viability, the sarin-exposed chicks
showed deﬁcits in imprinting performance (Fig. 1). Whereas chicks in
the control group showed a preference score above 0.8, those exposed
to 2 or 6 μg/kg of sarin showed much lower values, representing
nearly a 50% loss of imprinting performance. However, the effect was
lost in the group receiving the highest dose of sarin (12 μg/kg).
None of the sarin doses elicited signiﬁcant cholinesterase
inhibition in the hatched chicks (Fig. 2A), nor did they show any
deﬁcits in ChAT activity in any of the brain regions (Fig. 2B). In
contrast, HC3 binding showed signiﬁcant reductions at all sarin doses
(Fig. 3A); although the effects were smaller in the cerebral cortex than
in the other two regions, there was no signiﬁcant treatment×region
interaction, indicating the need for caution in interpreting any
differences in regional selectivity. However, because HC3 binding is
inﬂuenced by the density of cholinergic innervation as well as by
cholinergic presynaptic activity, we also determined the HC3 binding
as the ratio to ChAT, the constitutive marker for cholinergic terminals,
so as to give an index of impulse activity per terminal (Fig. 3B). Again,
even the lowest dose of sarin elicited a signiﬁcant reduction, and with
this measure, a signiﬁcant treatment×region interaction emerged,
reﬂecting a smaller, nonsigniﬁcant effect in the cerebral cortex as
compared to the robust, signiﬁcant reductions seen in the other two
regions.
Similar to our previous ﬁndings for chlorpyrifos [10], prehatch
exposure to sarin reduced the concentration of PKC isoforms in the
left IMHV (Fig. 4). Across all sarin doses, PKC subtypes and subcellular
fractions, 60% of the samples showed a reduction in PKC, a signiﬁcant
difference (pb0.003) from the expected random incidence of 50%; the
magnitude of the median decrease was 37%. Although each dose
group showed the same trend, i.e. reduction in PKC, the effect was
individually signiﬁcant only in the 6 μg/kg group, in which 70% of the
samples showed a lowering of PKC, with a median decrease of 38%.
We then examined PKC subtypes and subcellular fractions within that
dose group. All three subtypes showed a higher-than-normal
incidence of PKC values below the paired control (68% for PKCα,
66% for PKCβ, 63% for PKCγ). Although the latter was (barely) not
individually statistically signiﬁcant, the incidence was itself not
distinguishable from the signiﬁcant differences seen for the α and β
isoforms, so it is unlikely that there were subtype-selective differ-
ences; indeed, the median magnitude of the decrease was also similar
for the three isoforms: 42% for α, 34% for β, 42% for γ. There was,
however, a notable selectivity for membrane-associated PKC as
opposed to cytosolic PKC. Whereas the incidence of decreases in
cytosolic PKCwas indistinguishable from random (52%), nearly 80% of
the membrane PKC samples were below the corresponding control, a
difference that was signiﬁcant both from random (pb0.0005) and
from the cytosolic proportions (pb0.0003); the magnitude of the
median decrease was 42%. Finally, we examined the three PKC
subtypes within the membrane fraction. Each one showed a higher
410 J. Yanai et al. / Neurotoxicology and Teratology 31 (2009) 406–412
411J. Yanai et al. / Neurotoxicology and Teratology 31 (2009) 406–412incidence of decreases from the expected random values: 73% for
PKCα and 81% for PKCβ and PKCγ. Although only the latter two were
statistically distinguishable from the random 50% value, it must be
noted that the successive subdivisions reduced the number of
determinations to the point where individual statistical tests become
insensitive; the nonsigniﬁcant PKCα effect was not distinguishable
from the signiﬁcant effects on the other two isoforms and in fact, the
median decrease for the α isoform was actually larger (55% for PKCα,
35% for PKCβ, 43% for PKCγ).
4. Discussion
To our knowledge, the current results represent the ﬁrst dem-
onstration that developmental exposure to sarin in doses that are
apparently subtoxic, producing no dysmorphology or reductions
in viability, nevertheless elicits neurobehavioral teratogenicity. Not
only did we identify cognitive impairment but we were also able to
show the presence of cholinergic and cell signaling deﬁcits. At
hatching, we did not detect any residual inhibition of cholinesterase
from the sarin treatments on incubation days 2 and 6. Nevertheless,
an initial effect on cholinesterase cannot be ruled out, since these
enzymes originate early in embryonic development, during the period
in which we gave sarin [15]; organophosphates have been shown to
evoke cholinesterase inhibition during this period [7]. Indeed,
inhibition at the highest dose may account for the nonmonotonic
dose–response curve found for impairment of imprinting behavior. In
the developing brain, acetylcholine provides trophic input that
promotes neuronal survival and differentiation [14], so that if the
proper balance is achieved, a small degree of cholinesterase inhibition
might actually offset some aspects of the deleterious effects. In
keeping with this interpretation, the same nonmonotonic dose–effect
relationship for behavioral deﬁcits has been noted in rodent models of
developmental exposure to organophosphate pesticides [16,35].
In our earlier work with chlorpyrifos, we found that cognitive
impairment was directly associated with deﬁcient cholinergic
signaling, characterized by a reduction in HC3 binding and in the
ability of cholinergic receptor stimulation to evoke translocation of
PKCβ and PKCγ to the membrane [10,29,32]. Similarly, with sarin we
found a signiﬁcant deﬁcit in HC3 binding without a reduction in ChAT,
as well as reductions in the concentrations of PKC isoforms, with
particular loss in the membrane fraction, evaluated immediately after
imprinting, a behavior which depends upon cholinergic activation in
the left IMHV. HC3 binding reﬂects the concentration of high-afﬁnity
presynaptic choline transporters, the rate-limiting factor in acetyl-
choline biosynthesis, which highly reﬂects presynaptic neuronal
activity [27]. Accordingly, our ﬁnding a reduction in HC3 binding
without any signiﬁcant decrease in ChAT, a constitutive marker for
cholinergic nerve terminals, connotes a deﬁciency in cholinergic
impulse ﬂow rather than a loss of innervation, as conﬁrmed by the
decrease in the HC3/ChAT ratio. The magnitude of this effect of sarin
seen here corresponds to that seen in rats with fetal or neonatal
exposure to chlorpyrifos, and which is known to produce cholinergic-
related behavioral deﬁcits [29,30]. Further, we saw the same regional
selectivity for chlorpyrifos given to developing chicks at the same ages
as those used in the current study, namely greater effects in striatum
and brainstem than in cerebral cortex [32]. Our results thus indicate a
deﬁciency in indices of cholinergic presynaptic activity of sufﬁcient
magnitude to compromise cognitive performance. As with the
behavioral effects, the dose–effect relationship for the synaptic
defects did not show a progressive increase with dose; by implication,Fig. 4. Effects of prehatch sarin exposure on the concentrations of PKC isoforms. Pie charts p
controls divided into the global set of values for all doses (top row) and then subdivided
membrane fraction (bottom row) according to the incidence of signiﬁcant differences. The re
shown at the top of each pie chart; the number of determinations showing an increase or de
references to color in this ﬁgure legend, the reader is referred to the web version of this areither the effect on presynaptic activity is already maximal at the
lowest dose of sarin (i.e. 2 μg/kg is sufﬁcient to occupy the upper, ﬂat
part of the dose–effect curve), or else the neural defects are limited by
the same positive trophic effect that obtunds the impact on behavioral
responses, thus truncating the dose–effect curve at higher exposures.
Ordinarily, this would be partially compensated by postsynaptic
supersensitivity. However, the simultaneous loss of signaling targets
(PKC)means that both presynaptic and postsynaptic deﬁcits converge
to create a loss of synaptic function and the corresponding behavioral
impairment. Indeed, the PKC deﬁcits, like the behavioral tests,
displayed nonmonotonic effects of sarin, with the most signiﬁcant
reductions found at the intermediate dose. As proof of a mechanistic
relationship between impaired cholinergic synaptic function and
behavioral deﬁcits, in earlier work we were able to reverse the
developmental effects of neuroteratogens by treatments in adulthood
that restore cholinergic function of these speciﬁc factors [11];
presumably, the same strategy should work for the effects of sarin, a
subject for our future investigations.
Despite the overall similarities in the neuroteratogenic effects of
sarin and chlorpyrifos, we noted a number of key differences. Sarin did
not evoke any decrease in hatchability, nor did it cause dysmorphol-
ogy, whereas in our earlier studies, chlorpyrifos did both [10,32].
Nevertheless, chlorpyrifos, like sarin, evoked neurobehavioral deﬁcits
below the threshold for these signs of systemic toxicity, so the lack of
comparable effects of sarin could simply be a difference in the dose–
effect relationships of the two organophosphates, rather than an
inherent disparity in their systemic effects; evaluations at higher
doses of sarin should resolve this minor question. At the cellular level,
we found reductions in all three PKC isoforms with developmental
exposure to sarin, whereas with chlorpyrifos we did not ﬁnd a
reduction for PKCα. By implication, the behavioral effects of sarin may
therefore extend beyond those seen for chlorpyrifos; because
imprinting behavior is not dependent on the α-subtype [10], our
tests would not have detected a difference and clearly, additional
work with a wider array of behavioral tests is warranted. Further, the
impact of sarin on PKC isoforms is clearly a speciﬁc, developmental
event. Sarin exposure in the adult, even at the LD50, produces only
short-term changes in PKC expression that are limited to speciﬁc
subtypes in only a few brain regions and are not selective for the
membrane fraction, the speciﬁc component that is associated with
neurotransmitter receptor signaling [4]. In contrast, we found
widespread reductions in all subtypes throughout the brain, lasting
weeks beyond the exposure period, and selective for the membrane
fraction.
There are a number of key differences between chlorpyrifos and
sarin that contribute to some of the divergent effects. Chlorpyrifos is
metabolically converted to chlorpyrifos oxon, which is the active
cholinesterase inhibitor, whereas sarin acts directly, without requir-
ing conversion. Thus, whereas cholinesterase inhibition from chlor-
pyrifos can occur only after the development of the necessary
cytochrome P450 enzymes, sarin can act at any point in development.
Second, whereas chlorpyrifos and the other organophosphate
pesticides are chemically stable, sarin has a short half-life (hours) in
aqueous solutions, so that its duration of action is likely to be much
shorter [28]. However, we found effects of sarin at much lower doses
than for chlorpyrifos, emphasizing again that sarin is particularly
neuroteratogenic despite its short duration of action. Other differ-
ences may emerge when mammalian models are examined. For
example, sarin may not penetrate the placental barrier as readily as
the organophosphate pesticides or may be degraded more rapidly inresent proportions of animals with scores below (blue) and above (red) the respective
by dose, subtype (second row), subcellular fraction (third row), and subtype in the
sults of the χ2 test for observed vs. expected frequencies of increases and decreases are
crease is indicated within each pie section. NS, not signiﬁcant. (For interpretation of the
ticle.)
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However, our results point to potentially greater adverse effects of
sarin even if these factors lower the exposure substantially below
those seen with the pesticides.
In conclusion, our results provide the ﬁrst evidence that sarin is a
neurobehavioral teratogen at exposures that do not elicit signs of
systemic toxicity. As with our earlier work with chlorpyrifos [10,32],
sarin exposure produces cognitive impairment in association with
deﬁcient cholinergic presynaptic function and postsynaptic signaling
mediated through PKC. Finally, the fact that we identiﬁed these
deﬁcits in an avian model means that the effects of sarin are indeed
mediated directly on the developing brain, rather than representing
secondary actions that could confound such relationships in a
mammalian model. In the event of a terrorist incident involving
sarin, there will be a wide circle of low-level exposures that are
nonsymptomatic and thus are likely to be undetected. Our results
indicate nevertheless that theremay be serious consequences for fetal
and neonatal brain development. Further, understanding the defects
and their mechanism is an important initial step toward designing
therapies that may offset or reverse the sarin-induced neurodevelop-
mental defects [3,11], an approach we are currently investigating in
the chick model [5].
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